Health condition
Proton beam therapy UK criteria
Proton beam therapy deposits radiation with millimetre precision and minimal exit dose, benefiting selected tumours near critical structures; the NHS provides it at The Christie and UCLH against national indication lists, with a formal panel reviewing referrals.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Protons stop at their target, sparing tissue beyond it - the core physical advantage
-
NHS-approved indications include skull base chordoma and chondrosarcoma, many childhood and young-adult cancers, and selected sarcomas
-
A national panel assesses referrals made by your oncologist against these criteria
-
For most common adult cancers, evidence shows no advantage over modern photon radiotherapy
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
The physics is the argument: conventional X-ray beams pass through the body, dosing tissue before and beyond the tumour, while protons release their energy at a set depth and stop. Where a tumour presses against the brainstem, optic nerves or spinal cord, or where the patient is a child whose developing tissues pay compound interest on every stray gray, that difference is clinically meaningful - the reasoning behind the NHS indication list and its emphasis on skull base tumours and younger patients.
Diagnosis and treatment routes
Access is deliberately structured: your clinical oncologist refers into the national proton service, a specialist panel confirms the indication, and treatment proceeds at Manchester or London with accommodation support where needed - overseas referral having largely ended since the UK centres opened. Equally important is the honest converse: for prostate, breast and most common adult cancers, trials have not shown protons outperform state-of-the-art photon techniques, and private marketing suggesting otherwise deserves scepticism and a frank discussion with your oncologist. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant clinical oncologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Proton beam therapy UK criteria.
Quick, plain-English answers to what people ask us most.
-
What is proton beam therapy?
Proton beam therapy is a specialised form of radiotherapy using protons instead of standard X-rays, which allows more precise targeting of tumours while reducing radiation exposure to surrounding healthy tissue.
-
How does proton beam therapy differ from conventional radiotherapy?
Protons deposit most of their energy at a specific depth within the body and then stop, unlike conventional X-ray radiotherapy, which continues to deposit energy beyond the tumour; this property allows proton therapy to potentially spare more surrounding healthy tissue.
-
What are the NHS criteria for accessing proton beam therapy in the UK?
NHS access is generally reserved for specific cancer types where proton therapy offers a clear advantage over conventional radiotherapy, particularly certain paediatric cancers and tumours located near critical structures where minimising radiation to surrounding tissue is especially important.
-
Which cancers are most commonly treated with proton beam therapy on the NHS?
Certain brain and spinal tumours, particularly in children, and some rare tumours located near sensitive structures such as the eye or skull base are among the cancers where NHS proton therapy access criteria are most commonly met.
-
Can I access proton beam therapy privately if I don't meet NHS criteria?
Yes, private proton beam therapy is available in the UK and abroad for patients who don't meet strict NHS eligibility criteria but for whom their oncology team feels there may still be a potential benefit.
-
Is proton beam therapy more effective than conventional radiotherapy?
For many cancer types, both approaches show similar effectiveness at controlling the cancer itself; the main advantage of proton therapy is generally reduced side effects from radiation exposure to surrounding healthy tissue rather than superior cancer control in all cases.
-
How long does a course of proton beam therapy typically take?
This varies by cancer type and treatment plan, but often involves daily sessions over several weeks, similar in overall duration to a comparable course of conventional radiotherapy.
-
NHS proton therapy vs private proton therapy — what's the difference?
NHS proton therapy is available free of charge but only for specific, strictly defined clinical criteria, while private proton therapy offers broader access for patients and cancer types outside these strict criteria, at a personal cost.
-
How is eligibility for NHS proton beam therapy assessed?
This is assessed by a specialist multidisciplinary team, considering the specific cancer type, location, and whether proton therapy would offer a clear advantage over standard radiotherapy for that individual case.
-
When should I discuss this option, and how quickly can I be seen privately?
Discuss proton beam therapy suitability with your oncology team as part of your treatment planning. Private specialist oncology consultation to explore this option is typically available within about two weeks, faster than some NHS specialist referral pathways.